Skip to main content

Table 4 Reason for declining study participation

From: Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

Source

Time commitments

Location

Not interested

Other

Drug concerns

Clinics

13 (16%)

1 (1%)

8 (10%)

2 (3%)

1 (1%)

Register

15 (19%)

6 (8%)

1 (1%)

3 (4%)

0 (0%)

Internet

18 (23%)

7 (9%)

3 (4%)

2 (3%)

0 (0%)

Back to article page

Trials

ISSN: 1745-6215